ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Comparison of the Clinical Efficacy of Droplet Digital Polymerase Chain Reaction and Immunohistochemistry for the Detection of BRAF-V600E Mutation in Colorectal Cancer

Zhai, Weike; Xu, Yangwei; Huang, Shengyi; Cai, Weizhen; Li, Zhou*南方医科大学
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS2023-12DOI: 10.23812/j.biol.regul.homeost.agents.20233712.648
6阅读
引用收藏
分享

摘要

Background: The use of disease screening is limited in colorectal cancer (CRC) because of its unique location, and CRC patients are usually in advanced stages at the time of diagnosis. B-Raf proto-oncogene (BRAF)-V600E mutation is observed in tumors, and BRAF-V600E-mutant metastatic CRC is an aggressive subgroup. Droplet digital polymerase chain reaction (ddPCR) is a specific method for detecting circulating tumor DNA (ctDNA) mutations. This study used BRAF detection on cancer tissue as a standard for verifying the accuracy and heterogeneity of ddPCR in the plasma of CRC patients.Methods: A total of 147 CRC patients were recruited and their clinical data were obtained. Plasma samples were collected from patients to determine cell-free DNA (cfDNA) concentration and ddPCR, and cancer tissues were used for immunohistochemistry (IHC) assay. The effect of BRAF-V600E on patient prognosis was analyzed by Kaplan-Meier curve.Results: cfDNA was markedly increased in patients with CRC metastasis and was positively correlated with the size of non-metastatic tumors. The patients with BRAF-V600E mutation had a lower 5-year survival rate than those without the mutation, suggesting that BRAF-V600E mutation is a potential target for CRC humoral biopsy. Overall, there were some significant differences concerning the detection rates of IHC and ddPCR and the main distribution of ddPCR in multi-detected cases and stage III cases (p < 0.001).Conclusion: This study shows the feasibility of using ddPCR to detect BRAF-V600E in the plasma of CRC patients and the differences between ddPCR and IHC, providing support for the establishment of a CRC detection technique.

学科与关键词

关键词
colorectal cancerdroplet digital PCRimmunohistochemistryBRAF-V600E
相关
加载中…
  • The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta‐analysis
    Wenli Xie; Li Xie; Xianrang Song2019.
  • Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients.
    Taly Valerie; Pekin Deniz; Benhaim Leonor; Kotsopoulos Steve K; Le Corre Delphine; Li Xinyu; Atochin Ivan; Link Darren R; Griffiths Andrew D; Pallier Karine; Blons Hélène; Bouché Olivier; Landi Bruno; Hutchison J Brian; Laurent-Puig Pierre2013.
  • Circulating Tumor DNA Analysis: Clinical Implications for Colorectal Cancer Patients. A Systematic Review.
    Bach, Sander; Sluiter, Nina R; Beagan, Jamie J; Mekke, Joost M; Ket, Johannes C F; van Grieken, Nicole C T; Steenbergen, Renske D M; Ylstra, Bauke; Kazemier, Geert; Tuynman, Jurriaan BJNCI Cancer Spectr, 2019, 3(3): pkz042.
查看全部 →

发表信息

论文状态
公开发表
期刊
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
发表日期
2023-12
卷期
第 37 卷, 第 12 期
页码
6851-6858
DOI
10.23812/j.biol.regul.homeost.agents.20233712.648
语言
ENGLISH
成果收录
SCIE

作者

  • Z

    Zhai, Weike (第一作者)

    southern med univ

  • X

    Xu, Yangwei

    southern med univ

查看全部 5 位作者收起作者
  • H

    Huang, Shengyi

    southern med univ

  • C

    Cai, Weizhen

    southern med univ

  • L

    Li, Zhou (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417